Roy S. Herbst MD, PhD, Chief of Medical Oncology, Director for Translational Research, Clinical Research Program Leader, Thoracic Oncology Program, Yale Cancer Center, explores the driver mutations and molecular testing techniques that can be utilized to help determine an effective treatment for patients with lung cancer. Find out more, at http://www.onclive.com/onclive-tv/Dr-...